The University of Michigan Medical School and his colleagues, Dr. JB Ammori that radiotherapy combined gemcitabine (Gem / RT) as a new means of adjuvant therapy is expected for patients with advanced pancreatic cancer, but its side effects limit its application.
More...I am suffering from prostate hyperplasia, recently accepted the transurethral resection of prostate. After resection of the prostate tissue, the pathological examination revealed cancerous lesions, it allows me great mental burden. Whether this will be the development of cancer, the treatment needs to be done further? — Hebei readers afternoon LI
A: The current benign prostate disease (mainly BPH) for the diagnosis, after resection of the prostate biopsy of the prostate cancer found that the accident, called sporadic cancer. This type of prostate cancer incidence rate of about 3% to 10%.
More...Japan's Tokyo Komagome Hospital Dr. Okamoto and his colleagues selected 144 cases of pancreatic cancer patients, intraoperative radiotherapy and analysis of the efficacy of radiation therapy. Patients were divided into 2 groups: group 1 included 65 patients with unresectable tumors using shunt surgery; Group 2 included 68 cases of patients with tumor resection. In addition, the PWC study, 11 patients with radiation therapy from around the hemodynamic changes of pancreatic arterial infusion chemotherapy after them.
More...Bicalutamide (Casodex), an anti - androgen-corticosteroids, which can be used as the treatment of advanced prostate cancer assistant drug, may also in the treatment of early prostate cancer play an important role. According to Canada "Medical Post" (2001,37:27), the study of 23 countries into the 8113 cases (38 ~ 93 years) and the limitations of locally advanced prostate cancer were three prospective, double-blind, randomized, placebo-controlled study. 4,052 cases received bicalutamide 150mg per Yue treatment; 4,061 cases were receiving placebo treatment two years and acceptable standard resection or radiotherapy. Right to be diagnosed in patients before diagnosis only radiotherapy. Follow-up medication group 4,052 cases, 4,061 cases placebo group. Results cancer medication group progress risk reduction 47%, the survival rate increased by about 20%. A very small number of patients (including the elderly) because of adverse reactions stopping medication. In each hot flashes and impotence 9% (placebo group were 5.2% and 6.1%).
Urological Institute Europe (EAU) in the first prostate cancer treatment guidelines published in 2001. In the past few years, whenever affect prostate cancer (CaP) clinical treatment of the important changes, EAU Guide will be updated. In August 2005, EAU again updated the prostate cancer treatment guidelines. From www.uroweb.org new website will be a complete version of the Guide.
Working group on new data from the literature review, in accordance with evidence-based medicine (EBM), insert the evidence and recommended grade level, so as to help readers better understand the quality of the information recommended.
More...Early patients confined to the prostate capsule possible prostate cancer within the prostate surgery; Patients with advanced feasible spermatheca, including prostate cancer radical mastectomy; Not resection of prostate, testicular bilateral resectability, ease back pain.
② radiotherapy
With cobalt 60, or linear accelerator radiation prostate partial abdominal and pelvic lymph nodes.
③ chemotherapy
A commonly used chemotherapy drug cyclophosphamide, 5 - 5-fluorouracil, nitrogen mustard and other anticancer drugs. Joint use can reduce their reaction to alleviate symptoms of a long effect.
④ endocrine therapy
More...